Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity.
about
Metabolic Polymorphisms and Clinical Findings Related to Benzene Poisoning Detected in Exposed Brazilian Gas-Station WorkersAddressing human variability in next-generation human health risk assessments of environmental chemicalsA method to screen U.S. environmental biomonitoring data for race/ethnicity and income-related disparityPredictors of blood trihalomethane concentrations in NHANES 1999-2006.Herbal medicines in Brazil: pharmacokinetic profile and potential herb-drug interactions.Synergistic association of PTGS2 and CYP2E1 genetic polymorphisms with lung cancer risk in northeastern Chinese.Trichloroethylene biotransformation and its role in mutagenicity, carcinogenicity and target organ toxicity.Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan populationGenetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL).Trihalomethane exposure and biomonitoring for the liver injury indicator, alanine aminotransferase, in the United States population (NHANES 1999-2006).Trapping of cis-2-butene-1,4-dial to measure furan metabolism in human liver microsomes by cytochrome P450 enzymesModeling the Human Kinetic Adjustment Factor for Inhaled Volatile Organic Chemicals: Whole Population Approach versus Distinct Subpopulation ApproachHypothesis-based weight-of-evidence evaluation and risk assessment for naphthalene carcinogenesis.Prolonged toxicity after amitriptyline overdose in a patient deficient in CYP2D6 activityNicotinamide N-oxidation by CYP2E1 in human liver microsomes.Association between CYP2E1 polymorphisms and risk of gastric cancer: An updated meta-analysis of 32 case-control studies.Environmental toxin-linked nonalcoholic steatohepatitis and hepatic metabolic reprogramming in obese mice.Candidate gene linkage approach to identify DNA variants that predispose to preterm birth.Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment.Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs.Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.Characterization of the human kinetic adjustment factor for the health risk assessment of environmental contaminants.Toxicogenetic profile and cancer risk in Lebanese.CYP2E1 autoantibodies in liver diseasesPharmacogenetics of drug-metabolizing enzymes in Italian populations.Update meta-analysis of the CYP2E1 RsaI/PstI and DraI polymorphisms and risk of antituberculosis drug-induced hepatotoxicity: evidence from 26 studies.Moderate Alcohol Use and Insulin Action in Chronic Hepatitis C InfectionAssociation between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma.Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs.Impact of moderate alcohol discontinuation on insulin action and secretion in Latinos with and without hepatitis C.Toxicological Implications of Mitochondrial Localization of CYP2E1.CYP2E1 T7632A and 9-bp insertion polymorphisms and colorectal cancer risk: a meta-analysis based on 4,592 cases and 5,918 controls.Effects of polymorphisms in alcohol metabolism and oxidative stress genes on survival from head and neck cancer.Assessing human variability in kinetics for exposures to multiple environmental chemicals: a physiologically based pharmacokinetic modeling case study with dichloromethane, benzene, toluene, ethylbenzene, and m-xylene.Pregnancy and pharmacogenomics in the context of drug metabolism and response.
P2860
Q28384457-21ACE348-4363-419D-88E7-DB2FC785B48DQ28393541-C4427252-39DC-4191-8724-2537E08CB0D1Q28394407-196C43C4-0E71-438B-ACFE-944D848BD6C3Q33840984-9F350279-C4A9-46ED-A96C-08D550CEBF67Q33867239-6AFA7701-B91D-4F19-A9D4-190C75D16245Q34326547-C7C72BB1-10A7-40BF-9B56-D46742038EE4Q34626393-1703A41E-9EEC-4EAB-9D9F-8C387CA066ADQ34986858-E2EF65BC-50B6-48D6-95FE-A9786405D47FQ35638655-E454114B-BAC2-45F3-846B-FCFBDF7BB3DCQ35711933-F6E550AB-4D69-405C-A696-435311BFE497Q35776642-7693DA4D-6FFE-4DC8-AA13-B756130B29CBQ35864881-C2B470D4-05FF-47E2-A77C-EF46D45AC661Q36518971-B9B8785E-BC9A-48FA-B361-473FE303F598Q36548888-1C32AE19-5711-458B-8C5C-54E773F62076Q36642348-71FC81D9-54E2-4D18-94FE-194736CBC29EQ36953408-641679CD-D218-4261-A5DA-04DC74B8800EQ37000017-73B08CA1-7A06-423B-A508-86B7B14FB814Q37088248-3EF1F170-5C1D-4776-A89F-09556B52B923Q37775981-AADF66B7-D8C7-47F5-9EC0-C87CC39F02EFQ37892531-FBB81DE6-7332-4BF4-BFB3-5C9C654E994AQ38099753-1CA46FFC-F453-4352-8568-34AB2214878FQ38137867-3A642BF2-31F4-45C3-9632-6037523EF5BBQ38195853-473DAFCB-E03E-477B-AFD2-02601B568047Q38280871-7B90225B-F198-40AD-8902-D36CB14FDE4EQ38295313-950762BA-11E0-49C8-8AC1-6A34C29374E1Q38381479-5A7047AB-7F77-4409-A87B-A6F97007DC19Q39895389-C2D1C7F2-A9A2-43E3-A231-C57C5CECC54CQ40091055-EEB733CD-C043-4E92-BD7D-D588016102EEQ42284821-0B27B3AD-37D5-40B0-8B18-4AA9B0DFEAD4Q46597840-8362288D-E0FA-4B13-890F-8D0AF35F0F3FQ47909554-8004B765-BE64-4499-96DC-AF8A21CDF1B0Q51025967-F8DBDFAD-A43B-4C88-938E-478FBE0A8A71Q51029230-3FC8294D-E066-41E1-982D-4940F8E8E3C5Q53573948-E637E5EA-90DF-48BF-A6D4-6B57C557528EQ54659609-C4CB9294-FAF9-4DF3-8146-E96E7BC51EAA
P2860
Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity.
@en
Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity.
@nl
type
label
Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity.
@en
Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity.
@nl
prefLabel
Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity.
@en
Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity.
@nl
P2093
P2860
P1476
Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity.
@en
P2093
Babasaheb Sonawane
Dale Hattis
Douglas O Johns
Gary Ginsberg
Kathryn Z Guyton
Pat Neafsey
P2860
P304
P356
10.1080/10937400903158359
P577
2009-01-01T00:00:00Z